Clinical Efficacy of Immune Checkpoint Inhibitors in Non–Small Cell Lung Cancer Patients with Liver Metastases: A Network Meta-Analysis of Nine Randomized Controlled Trials

PURPOSE: This network meta-analysis (NMA) was conducted to compare the efficacy of immune checkpoint inhibitors in advanced non–small cell lung cancer (NSCLC) patients with liver metastases. MATERIALS AND METHODS: English literature was retrieved from the PubMed, American Society of Clinical Oncolog...

Descripción completa

Detalles Bibliográficos
Autores principales: Yin, Qing, Dai, Longguo, Sun, Ruizhu, Ke, Ping, Liu, Liya, Jiang, Bo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Cancer Association 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9296924/
https://www.ncbi.nlm.nih.gov/pubmed/34696564
http://dx.doi.org/10.4143/crt.2021.764

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9296924/
https://www.ncbi.nlm.nih.gov/pubmed/34696564
http://dx.doi.org/10.4143/crt.2021.764

Ejemplares similares